Envoy Medical Inc./$COCH
1D1W1MYTD1Y5YMAX
About Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
- Ticker
- $COCH
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 45
- Headquarters
- White Bear Lake, United States
- Website
- www.envoymedical.com
COCH Metrics
BasicAdvanced
$56M
-
-$0.51
1.89
-
Price and volume
Market cap
$56M
Beta
1.89
52-week high
$1.89
52-week low
$0.36
Average daily volume
150K
Financial strength
Current ratio
1.735
Quick ratio
1.563
Long term debt to equity
18.354
Total debt to equity
21.927
Interest coverage (TTM)
-49.75%
Profitability
EBITDA (TTM)
-23.128
Gross margin (TTM)
-293.72%
Net profit margin (TTM)
-11,304.83%
Operating margin (TTM)
-11,319.32%
Management effectiveness
Return on assets (TTM)
-86.53%
Return on equity (TTM)
178.87%
Valuation
Price to revenue (TTM)
197.327
Price to book
15.27
Price to tangible book (TTM)
15.27
Price to free cash flow (TTM)
-1.881
Free cash flow yield (TTM)
-53.16%
Free cash flow per share (TTM)
-0.389
Growth
Revenue change (TTM)
-6.76%
Earnings per share change (TTM)
-63.58%
3-year revenue growth (CAGR)
-1.71%
3-year earnings per share growth (CAGR)
22.75%
COCH News
AllArticlesVideos
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
Newsfile Corp3 weeks ago
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
Newsfile Corp1 month ago
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
Newsfile Corp1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.